Stock listing
BCRX Stock Price, News, Filings & Events — Biocryst Pharmaceuticals, Inc.
Selected listing: BCRX · BIVA · MXN · MX
This page tracks Biocryst Pharmaceuticals, Inc.'s BCRX:BIVA listing on BIVA in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BCRX:BIVA. BCRX:BIVA is the stock-level entry point for investors researching Biocryst Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Biocryst Pharmaceuticals, Inc. (BCRX) is a public company based in the United States, specializing in the development of innovative therapies for rare diseases. The company has a market capitalization of approximately $2.37 billion. Biocryst focuses on creating treatments that address unmet medical needs, leveraging its expertise in biopharmaceuticals.
- Ticker
- BCRX:BIVA
- Asset type
- Stock
- Market cap
- $2.44B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BIVA
- Currency
- MXN
Biocryst Pharmaceuticals, Inc. BCRX:BIVA stock context
This page tracks Biocryst Pharmaceuticals, Inc.'s BCRX:BIVA listing on BIVA in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BCRX:BIVA. BCRX:BIVA is the stock-level entry point for investors researching Biocryst Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Biocryst Pharmaceuticals, Inc. (BCRX) is a public company based in the United States, specializing in the development of innovative therapies for rare diseases. The company has a market capitalization of approximately $2.37 billion. Biocryst focuses on creating treatments that address unmet medical needs, leveraging its expertise in biopharmaceuticals.
Latest news from Biocryst Pharmaceuticals, Inc.
BioCryst Announces Approval of ORLADEYO® for Pediatric HAE Patients in Japan
August 25, 2026
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
August 14, 2026
BioCryst Reports Second Quarter 2026 Financial Results
August 5, 2026
BioCryst to Report Second Quarter 2026 Financial Results on August 5
July 22, 2026
BioCryst Appoints David W. Jenkins as Chief Scientific Officer
July 15, 2026
Research Biocryst Pharmaceuticals, Inc.
Biocryst Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for BCRX:BIVA.
Biocryst Pharmaceuticals, Inc. company profile
View the public company page for Biocryst Pharmaceuticals, Inc. on 6ix.
Biocryst Pharmaceuticals, Inc. news
Read company news and market updates connected to Biocryst Pharmaceuticals, Inc..
Biocryst Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Biocryst Pharmaceuticals, Inc..
Alternate listings
BCRX:NASDAQ
US · USD
Alternate listing for Biocryst Pharmaceuticals, Inc.; the primary context on this page is BCRX:BIVA.
BO1:TRADEGATE
DE · EUR
Alternate listing for Biocryst Pharmaceuticals, Inc.; the primary context on this page is BCRX:BIVA.
BO1:GETTEX
DE · EUR
Alternate listing for Biocryst Pharmaceuticals, Inc.; the primary context on this page is BCRX:BIVA.
896047:LSX
DE · EUR
Alternate listing for Biocryst Pharmaceuticals, Inc.; the primary context on this page is BCRX:BIVA.
BCRX:BMV
MX · MXN
Alternate listing for Biocryst Pharmaceuticals, Inc.; the primary context on this page is BCRX:BIVA.
896047:LS
DE · EUR
Alternate listing for Biocryst Pharmaceuticals, Inc.; the primary context on this page is BCRX:BIVA.
BO1:FWB
DE · EUR
Alternate listing for Biocryst Pharmaceuticals, Inc.; the primary context on this page is BCRX:BIVA.
BCRX:BOATS
US · USD
Alternate listing for Biocryst Pharmaceuticals, Inc.; the primary context on this page is BCRX:BIVA.
BO1:SWB
DE · EUR
Alternate listing for Biocryst Pharmaceuticals, Inc.; the primary context on this page is BCRX:BIVA.
BO1:DUS
DE · EUR
Alternate listing for Biocryst Pharmaceuticals, Inc.; the primary context on this page is BCRX:BIVA.
BO1:MUN
DE · EUR
Alternate listing for Biocryst Pharmaceuticals, Inc.; the primary context on this page is BCRX:BIVA.
BO1:BX
CH · CHF
Alternate listing for Biocryst Pharmaceuticals, Inc.; the primary context on this page is BCRX:BIVA.